New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day

NCT01360021 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

214

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Symbicort
DRUG: Symbicort
DRUG: Budesonide

Sponsor

AstraZeneca